The company is not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale by the selling ...

ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on January 2, 2025 ...

Olema Pharmaceuticals, Inc. (“Olema” or “”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast ...

Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...

Olema Pharmaceuticals Inc (OLMA) stock saw a modest uptick, ending the day at $5.83 which represents a slight increase of $0.22 or 3.92% from the prior close of $5.61. The stock opened at $5.61 and ...

Geode Capital Management LLC reduced its stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 11.8% ...

Novartis NVS announced positive top-line results from the late-stage STEER study on experimental candidate intrathecal ...

A Pulitzer Prize-winning weekly covering West Marin, including the towns of Point Reyes Station, Inverness, Bolinas, Stinson ...

A Pulitzer Prize-winning weekly covering West Marin, including the towns of Point Reyes Station, Inverness, Bolinas, Stinson ...

State Street Corp increased its holdings in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 1.1% in the ...

Heavy winds over the weekend added to woes, flooding parts of Marin and causing large swaths of power outages, including a citywide outage in Novato over the weekend. Calmer weather is in store this ...